Mati Therapeutics' Unattributed - II Round

Mati Therapeutics raised a round of funding on October 10, 2014.

Mati Therapeutics is developing a platform to provide sustained drug delivery to the surface of the eye.…

Articles about Mati Therapeutics' Unattributed - II Round: